A detailed history of Waterloo Capital, L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Waterloo Capital, L.P. holds 1,251 shares of ZTS stock, worth $223,653. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,251
Previous 1,484 15.7%
Holding current value
$223,653
Previous $251 Million 13.6%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $33,910 - $41,667
-233 Reduced 15.7%
1,251 $217 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $176,935 - $213,535
-1,068 Reduced 41.85%
1,484 $251 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $386,474 - $510,629
2,552 New
2,552 $504 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Waterloo Capital, L.P. Portfolio

Follow Waterloo Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waterloo Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Waterloo Capital, L.P. with notifications on news.